Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

49.78
-9.3700-15.84%
Post-market: 50.650.8700+1.75%19:59 EDT
Volume:74.58M
Turnover:3.86B
Market Cap:11.25B
PE:63.11
High:57.45
Open:57.12
Low:49.60
Close:59.15
52wk High:72.98
52wk Low:18.33
Shares:226.02M
Float Shares:197.51M
Volume Ratio:2.20
T/O Rate:37.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7888
EPS(LYR):0.5837
ROE:41.88%
ROA:6.94%
PB:20.00
PE(LYR):85.29

Loading ...

Trump's Weight-Loss Drug Push May Put These ETFs On A Diet

Benzinga_recent_news
·
Yesterday

Hims & Hers CEO Cashes Out $11 Million in Shares

Deep News
·
Yesterday

Hims & Hers Health (HIMS) Stock Tanks 13% after CEO Discloses Stock Sale

TIPRANKS
·
Yesterday

Stock Track | Hims & Hers Health Plummets 13% as Trump Signals Weight-Loss Drug Price Cuts

Stock Track
·
Oct 17

Stock Track | Hims & Hers Health Plummets 13.05% as Trump's Comments Threaten Weight-Loss Drug Business Model

Stock Track
·
Oct 17

US Stock Update | Hims & Hers Health (HIMS.US) Drops Over 10%, Cumulative Decline of 15% in Two Days

Stock News
·
Oct 17

Hims & Hers falls -8.6%

TIPRANKS
·
Oct 17

Why Hims & Hers Health Shares Are Sliding Friday

Benzinga_recent_news
·
Oct 17

HIMS Down 6%; Novo Nordisk, Eli Lilly Down About 3% After Trump Vows Weight-Loss Drug Price Cut

Reuters
·
Oct 17

Form 144 | Hims & Hers Health's Officer Andrew Dudum proposes to sell 175,661 shares, with a total value of approximately $11.03 Million.

Filings Track
·
Oct 17

Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem

Benzinga_recent_news
·
Oct 16

Option Movers|AMD's $240 Call Soars 750%; Hims's $60 Call Soars 1267%; Bank of America Shows Bullish Sentiment

Option Movers
·
Oct 16

Top Analyst Keeps Sell Rating on HIMS Stock Despite Buzz Around Women’s Health Expansion

TIPRANKS
·
Oct 16

Hims & Hers (HIMS.US) Launches Menopause and Perimenopause Treatment Services, Shares Surge Over 15% in One Day

Stock News
·
Oct 16

Hims & Hers Health Stock (HIMS) Soared 16% Today, Technical Indicators Still Suggest “Buy”

TIPRANKS
·
Oct 16

Weight-loss drugs shook up the stock market. Menopause treatments could be next.

Dow Jones
·
Oct 16

Investors Are Buying Hims & Hers Health Stock Following Wednesday's Platform Expansion Announcement

Benzinga_recent_news
·
Oct 16

Hims & Hers' Menopause Expansion Seen Boosting Customer Base -- Market Talk

Dow Jones
·
Oct 16

Hims & Hers' Menopause Offerings Seen With $17.3B Opportunity -- Market Talk

Dow Jones
·
Oct 16

Hims & Hers Health Launches Perimenopause and Menopause Care Under Hers Platform

MT Newswires Live
·
Oct 15